| Authors: |
Filimon S; Division of Cardiovascular Diseases, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA; Thalheimer Center for Cardio-Oncology, Division of Cardiology and Abramson Cancer Center, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA., Ghamari A; Cardio-Oncology Program, Division of Cardiology, Massachusetts General Hospital, Boston, Massachusetts, USA., Vakilpour A; Division of Cardiovascular Diseases, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA., Patel R; Division of Cardiology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA., Achar R; Division of Medical Oncology and Hematology, Department of Internal Medicine, Yale School of Medicine and Yale Cancer Center, New Haven, Connecticut, USA., Akhter N; Division of Cardiology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA., Shallis RM; Division of Medical Oncology and Hematology, Department of Internal Medicine, Yale School of Medicine and Yale Cancer Center, New Haven, Connecticut, USA., DeCara JM; Division of Cardiology, Department of Medicine, University of Chicago, Chicago, Illinois, USA., Altman J; Division of Hematology-Oncology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA., Smith A; Thalheimer Center for Cardio-Oncology, Division of Cardiology and Abramson Cancer Center, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA., Matthews A; Division of Hematology-Oncology, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA., Lai C; Division of Hematology-Oncology, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA., Brunner AM; Leukemia Program, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Farina KA; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York City, New York, USA., Gilman HK; Cardio-Oncology Program, Division of Cardiology, Massachusetts General Hospital, Boston, Massachusetts, USA., Neilan TG; Cardio-Oncology Program, Division of Cardiology, Massachusetts General Hospital, Boston, Massachusetts, USA., Upadhyay D; Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA., Chittams J; Department of Biobehavioral Health Sciences, School of Nursing, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Anazco F; Division of Hematology-Oncology, Department of Medicine, University of Chicago, Chicago, Illinois, USA., Patel AA; Division of Hematology-Oncology, Department of Medicine, University of Chicago, Chicago, Illinois, USA., Tremblay D; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York City, New York, USA., Scherrer-Crosbie M; Division of Cardiovascular Diseases, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA; Thalheimer Center for Cardio-Oncology, Division of Cardiology and Abramson Cancer Center, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA. Electronic address: marielle.scherrer-crosbie@pennmedicine.upenn.edu. |
